| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.9 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.018 | 0.9 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |